<DOC>
	<DOC>NCT02921711</DOC>
	<brief_summary>A prospective, multicenter, observational assessment of the safety and effectiveness of the LVIS® device in the treatment of wide necked intracranial aneurysms.</brief_summary>
	<brief_title>TRAIL: Treatment of Intracranial Aneurysms With LVIS® System</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>1. Patient or patient's legally authorized representative has been informed about the confidentiality of the study and has agreed to the collection of his/her personal data 2. Patient has a ruptured or unruptured intracranial aneurysm for which: The parent artery has a diameter ≥ 2.0mm and ≤ 4.5 mm; The aneurysm neck size is ≥ 4mm or its dometoneck ratio is &lt; 2 (wide neck) Endovascular treatment with coils and one or more LVIS® devices has been determined necessary for the patient by the multidisciplinary team 3. Patient is aged ≥ 18 years 4. Patient presents with a WFNS score between 0 and 3 5. Patient has agreed to attend followup appointments 1. The use of an endovascular stent other than LVIS® has been determined necessary 2. Patient presents with medical or surgical comorbidities limiting his/her life expectancy to less than one year 3. Patient has a contraindication to platelet inhibition treatment 4. Patient requires retreatment of an aneurysm previously treated with a stent 5. Patient is pregnant 6. Patient has multiple aneurysms to be treated in one procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>